These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 26937212)

  • 1. CRM1 inhibitor S109 suppresses cell proliferation and induces cell cycle arrest in renal cancer cells.
    Liu X; Chong Y; Liu H; Han Y; Niu M
    Korean J Physiol Pharmacol; 2016 Mar; 20(2):161-8. PubMed ID: 26937212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel reversible selective inhibitor of CRM1 for targeted therapy in ovarian cancer.
    Liu X; Chong Y; Liu H; Han Y; Niu M
    J Ovarian Res; 2015 Jun; 8():35. PubMed ID: 26055813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
    Niu M; Chong Y; Han Y; Liu X
    Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRM1/XPO1 is associated with clinical outcome in glioma and represents a therapeutic target by perturbing multiple core pathways.
    Liu X; Chong Y; Tu Y; Liu N; Yue C; Qi Z; Liu H; Yao Y; Liu H; Gao S; Niu M; Yu R
    J Hematol Oncol; 2016 Oct; 9(1):108. PubMed ID: 27733172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversible inhibitor of CRM1 sensitizes glioblastoma cells to radiation by blocking the NF-κB signaling pathway.
    Liu X; Tu Y; Wang Y; Zhou D; Chong Y; Shi L; Liu G; Zhang X; Wu S; Li H; Gao S; Niu M; Yu R
    Cancer Cell Int; 2020; 20():97. PubMed ID: 32256206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of chromosomal region maintenance 1 suppresses the migration and invasion of glioma cells via inactivation of the STAT3/MMP2 signaling pathway.
    Shan Q; Li S; Cao Q; Yue C; Niu M; Chen X; Shi L; Li H; Gao S; Liang J; Yu R; Liu X
    Korean J Physiol Pharmacol; 2020 May; 24(3):193-201. PubMed ID: 32392910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy.
    Gao W; Lu C; Chen L; Keohavong P
    J Thorac Oncol; 2015 May; 10(5):815-825. PubMed ID: 25629636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piperlongumine is a novel nuclear export inhibitor with potent anticancer activity.
    Niu M; Xu X; Shen Y; Yao Y; Qiao J; Zhu F; Zeng L; Liu X; Xu K
    Chem Biol Interact; 2015 Jul; 237():66-72. PubMed ID: 26026911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRM1-mediated nuclear export of proteins and drug resistance in cancer.
    Turner JG; Sullivan DM
    Curr Med Chem; 2008; 15(26):2648-55. PubMed ID: 18991627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of CRM1 inhibits the nuclear export of p27(Kip1) phosphorylated at serine 10 and plays a role in the pathogenesis of epithelial ovarian cancer.
    Wang Y; Wang Y; Xiang J; Ji F; Deng Y; Tang C; Yang S; Xi Q; Liu R; Di W
    Cancer Lett; 2014 Feb; 343(1):6-13. PubMed ID: 24018641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for RanBP1 in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export.
    Kehlenbach RH; Dickmanns A; Kehlenbach A; Guan T; Gerace L
    J Cell Biol; 1999 May; 145(4):645-57. PubMed ID: 10330396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
    Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of CRM1, a nuclear export receptor, in mRNA export in mammalian cells and fission yeast.
    Watanabe M; Fukuda M; Yoshida M; Yanagida M; Nishida E
    Genes Cells; 1999 May; 4(5):291-7. PubMed ID: 10421839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective nuclear export inhibitor KPT‑330 enhances the radiosensitivity of esophageal carcinoma cells.
    Xu J; Wu S; Li G
    Exp Ther Med; 2023 Jul; 26(1):326. PubMed ID: 37346402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
    Kimura T; Hashimoto I; Nagase T; Fujisawa J
    J Cell Sci; 2004 May; 117(Pt 11):2259-70. PubMed ID: 15126627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of cyclin B1 localization through regulated binding of the nuclear export factor CRM1.
    Yang J; Bardes ES; Moore JD; Brennan J; Powers MA; Kornbluth S
    Genes Dev; 1998 Jul; 12(14):2131-43. PubMed ID: 9679058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small Molecule Inhibitors of CRM1.
    Ferreira BI; Cautain B; Grenho I; Link W
    Front Pharmacol; 2020; 11():625. PubMed ID: 32574233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of the nuclear export protein, Crm1 (exportin 1), associates with human oesophageal squamous cell carcinoma.
    van der Watt PJ; Zemanay W; Govender D; Hendricks DT; Parker MI; Leaner VD
    Oncol Rep; 2014 Aug; 32(2):730-8. PubMed ID: 24898882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.